Safety and Efficacy of EXO-CD24 in Preventing Clinical Deterioration in Patients With Mild-Moderate ARDS

Safety and Efficacy Study of Acthar in Subjects With ARDS

NCT02113735 ·Status: WITHDRAWN ·Phase: PHASE2

Intrapleural Methylprednisolone Injection for Multiple Organ Failure With Acute Respiratory Distress Syndrome

NCT01423864 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of FDY-5301 in Major Trauma Patients in ICU

NCT04430283 ·Status: TERMINATED ·Phase: PHASE2

Steroids in Patients With Early ARDS

NCT00562835 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Placebo-Controlled Study of Auxora for the Extended Treatment of High- Risk Patients With Critical COVID-19 Pneumonia

NCT05171920 ·Status: WITHDRAWN ·Phase: PHASE2

Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)

NCT04609943 ·Status: TERMINATED ·Phase: PHASE1

Recovery and Survival of EryDex in Non-patient Volunteers

NCT02380924 ·Status: COMPLETED ·Phase: PHASE1

Effects and Safety of Infusion of Low-Doses of Methylprednisolone in Early ALI and ARDS in Children

NCT01757899 ·Status: WITHDRAWN ·Phase: PHASE2

Pharyngeal Electrical Stimulation for the Treatment of Post-extubation Dysphagia in Acute Stroke

NCT02470078 ·Status: COMPLETED ·Phase: NA

Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury

NCT02444858 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Effects of Neuromuscular Blocking Agents (NMBA) on the Alteration of Transpulmonary Pressures at the Early Phase of Acute Respiratory Distress Syndrome (ARDS)

NCT01573715 ·Status: UNKNOWN ·Phase: PHASE4

REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia

NCT04468971 ·Status: COMPLETED ·Phase: PHASE1

Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia

NCT06624436 ·Status: RECRUITING ·Phase: PHASE4

Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma

NCT03368092 ·Status: RECRUITING ·Phase: PHASE3

Adrenal Cortical Function and Vitamin A Deficiency in Sepsis

NCT03152474 ·Status: COMPLETED ·Phase: PHASE4

Lipid Infusion in Dialysis Patients With Endotoxemia

NCT00506454 ·Status: COMPLETED ·Phase: PHASE2

Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients

NCT00299650 ·Status: COMPLETED ·Phase: PHASE4

Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients

NCT05993390 ·Status: RECRUITING ·Phase: NA

Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade

NCT02403063 ·Status: COMPLETED ·Phase: PHASE4

Anabolic Steroids for Nutritional Rehabilitation of Critically Ill Patients

NCT00242463 ·Status: TERMINATED ·Phase: PHASE2

Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence

NCT02292628 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Sodium Lactate in Severe TBI

NCT06701760 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome

NCT01637272 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis

NCT01571297 ·Status: COMPLETED ·Phase: PHASE2

A Pilot Study Using Rocuronium to Prevent Intermediate Syndrome After Organophosphorus Insecticide Poisoning

NCT02147054 ·Status: COMPLETED ·Phase: PHASE2/PHASE3